Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Monograph Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 10
Average round size
info
The average size of a deal this fund participated in
$67M
Portfolio companies 9
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.10
Key employees Soon
Stages of investment
Early Stage Venture

Areas of investment

  • Biotechnology
  • Life Science
  • Therapeutics
  • Medical
  • Health Care

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Autobahn Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$100M24 Jul 2024 San Diego, California, United States

Nocion Therapeutics

Biotechnology
Health Care
Medical
$62M04 Mar 2024 Cambridge, Massachusetts, United States

Sudo Biosciences

Biopharma
$30M13 Feb 2024 Menlo Park, California, United States

Sudo Biosciences

Biopharma
$116M20 Dec 2023 Menlo Park, California, United States

ODAIA

Software
$25M01 May 2023 Old Toronto, Ontario, Canada

Maxion Therapeutics

Information Technology
Therapeutics
$17M15 Feb 2023 Cambridge, Cambridgeshire, United Kingdom

RegASK

Information Technology
Professional Services
SaaS
$10M16 Dec 2022 Singapore, Central Region, Singapore

Human Immunology Biosciences

Biotechnology
Life Science
Medical
Product Research
Therapeutics
$120M01 Nov 2022 San Francisco, California, United States

MiroBio

Biotechnology
Life Science
$109M29 Jun 2022 Oxford, England, United Kingdom

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Monograph Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 10
Average round size 67M
Peak activity year 2022
Lead investments 1
Follow on index 0.10
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Autobahn Therapeutics

Biotechnology
Health Care
Life Science
Therapeutics
$100M24 Jul 2024 San Diego, California, United States

Nocion Therapeutics

Biotechnology
Health Care
Medical
$62M04 Mar 2024 Cambridge, Massachusetts, United States

Sudo Biosciences

Biopharma
$30M13 Feb 2024 Menlo Park, California, United States

Sudo Biosciences

Biopharma
$116M20 Dec 2023 Menlo Park, California, United States

ODAIA

Software
$25M01 May 2023 Old Toronto, Ontario, Canada

Maxion Therapeutics

Information Technology
Therapeutics
$17M15 Feb 2023 Cambridge, Cambridgeshire, United Kingdom

RegASK

Information Technology
Professional Services
SaaS
$10M16 Dec 2022 Singapore, Central Region, Singapore

Human Immunology Biosciences

Biotechnology
Life Science
Medical
Product Research
Therapeutics
$120M01 Nov 2022 San Francisco, California, United States

MiroBio

Biotechnology
Life Science
$109M29 Jun 2022 Oxford, England, United Kingdom
Crunchbase icon

Content report

The following text will be sent to our editors: